- Home
- SPT vs MGTX Comparison
SPT vs MGTX Comparison
Compare SPT & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SPT | MGTX |
|---|---|---|
| Founded | 2010 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 651.7M | 579.5M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | SPT | MGTX |
|---|---|---|
| Price | $6.99 | $7.58 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 6 |
| Target Price | $21.70 | ★ $23.83 |
| AVG Volume (30 Days) | ★ 1.7M | 400.1K |
| Earning Date | 02-26-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $443,750,000.00 | $27,417,000.00 |
| Revenue This Year | $13.30 | N/A |
| Revenue Next Year | $11.23 | $569.48 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 13.09 | ★ 96.83 |
| 52 Week Low | $6.52 | $4.55 |
| 52 Week High | $33.97 | $9.73 |
Technical Indicators
Market Signals| Indicator | SPT | MGTX |
|---|---|---|
| Relative Strength Index (RSI) | 28.08 | 48.91 |
| Support Level | $6.52 | $7.16 |
| Resistance Level | $7.37 | $7.70 |
| Average True Range (ATR) | 0.56 | 0.40 |
| MACD | -0.12 | -0.01 |
| Stochastic Oscillator | 14.79 | 41.56 |
Price Performance
Historical ComparisonAbout SPT Sprout Social Inc
Sprout Social Inc develops a cloud software that brings together social messaging, data and workflows in a unified system of record, intelligence, and action. It has a centralized, secure and powerful platform that can scale horizontally across an organization to drive maximum business value. The firm generates majority revenue from software subscriptions.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.